My Lords, I join others in apologising for not being here at Second Reading—on medical grounds, in my case—which seems to be a consistent theme in this debate. In looking at the amendment and legislation today, it is important that we actually focus on what is there rather than debating—I appreciate…
My Lords, when the House of Lords Preterm Birth Committee released its report in November last year, it was an important contribution to our national conversation about preterm birth. It brought overdue attention to a complex but urgent challenge that affects over 45,000 babies born prematurely in E…
My Lords, whatever the claims and counterclaims of any deal by any Government, and whatever concerns may be raised today—I share some of those concerns, although some of us see the irony in that some of those raising concerns were very happy, only a short time ago, to see exactly the same conditions…
My Lords, the deal that has been struck is clearly limited in scope. However, it is clear that the Government see this as part one of a wider package that will develop and will be particularly significant in terms of pharmaceuticals, in which I think we will show a good deal of interest. It is also …